Is mPGES-1 a promising target for pain therapy?

被引:47
作者
Scholich, Klaus [1 ]
Geisslinger, Gerd [1 ]
机构
[1] Univ Frankfurt Klinikum, Pharmazentrum Frankfurt, ZAFES, D-60590 Frankfurt, Germany
关键词
D O I
10.1016/j.tips.2006.06.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclooxygenase (COX) inhibitors are widely used analgesic and anti-inflammatory drugs. Owing to undesirable effects caused by unselective COX inhibitors and selective COX-2 inhibitors, microsomal prostaglandin E-2 synthase-1 has been considered as an alternative target for the development of analgesic drugs. However, recent findings question the usefulness of this terminal synthase as a promising drug target for pain therapy.
引用
收藏
页码:399 / 401
页数:3
相关论文
共 16 条
  • [1] Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile
    Boulet, L
    Ouellet, M
    Bateman, KP
    Ethier, D
    Percival, MD
    Riendeau, D
    Mancini, JA
    Méthot, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (22) : 23229 - 23237
  • [2] Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain
    Broom, DC
    Samad, TA
    Kohno, T
    Tegeder, I
    Geisslinger, G
    Woolf, CJ
    [J]. NEUROSCIENCE, 2004, 124 (04) : 891 - 900
  • [3] CHEUNG Y, 2006, J CLIN INVEST, V74, P309
  • [4] Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice
    Eguchi, N
    Minami, T
    Shirafuji, N
    Kanaoka, Y
    Tanaka, T
    Nagata, A
    Yoshida, N
    Urade, Y
    Ito, S
    Hayaishi, O
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) : 726 - 730
  • [5] Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis
    Engblom, D
    Saha, S
    Engström, L
    Westman, M
    Audoly, LP
    Jakobsson, PJ
    Blomqvist, A
    [J]. NATURE NEUROSCIENCE, 2003, 6 (11) : 1137 - 1138
  • [6] Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
    Hata, AN
    Breyer, RM
    [J]. PHARMACOLOGY & THERAPEUTICS, 2004, 103 (02) : 147 - 166
  • [7] Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1
    Kamei, D
    Yamakawa, K
    Takegoshi, Y
    Mikami-Nakanishi, M
    Nakatani, Y
    Oh-ishi, S
    Yasui, H
    Azuma, Y
    Hirasawa, N
    Ohuchi, K
    Kawaguchi, H
    Ishikawa, Y
    Ishii, T
    Uematsu, S
    Akira, S
    Murakami, M
    Kudo, I
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) : 33684 - 33695
  • [8] Membrane-associated prostaglandin E synthase-I is required for neuropathic pain
    Mabuchi, T
    Kojima, H
    Abe, T
    Takagi, K
    Sakurai, M
    Ohmiya, Y
    Uematsu, S
    Akira, S
    Watanabe, K
    Ito, S
    [J]. NEUROREPORT, 2004, 15 (09) : 1395 - 1398
  • [9] Prostaglandin E synthase
    Murakami, M
    Nakatani, Y
    Tanioka, T
    Kudo, I
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 : 383 - 399
  • [10] Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2
    Murakami, M
    Naraba, H
    Tanioka, T
    Semmyo, N
    Nakatani, Y
    Kojima, F
    Ikeda, T
    Fueki, M
    Ueno, A
    Oh-ishi, S
    Kudo, I
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) : 32783 - 32792